The BSH Guidelines Official Podcast
autor: British Society for Haematology
Najnowszy odcinek
Use of andexanet alfa: A British Society for Haematology position…
Use of andexanet alfa: A British Society for Haematology position…
O tym podcaście
Short podcasts on current haematological guidelines and good practices papers produced by the British Society for Haematology
Odcinki
Najnowsze 20 z 87 odcinków
- Use of andexanet alfa: A British Society for Haematology position statement · 26 min · Odcinek 89During this podcast, Dr Richard Buka and Prof Deepa Arachchillage discuss the BSH Position Paper ‘Use of andexanet alfa: A British Society for Haematology position statement'…
- Reporting haemostasis assays in IU/dL—A recommendation for harmonisation (BSH H&T Task Force / UK NEQAS / UK HCDO) · 16 min · Odcinek 88Dr Will Lester and Dr Ian Jennings discuss the Reporting haemostasis assays in IU/dL—A recommendation for harmonisation (BSH H&T Task Force / UK NEQAS / UK HCDO) paper, published…
- BSH guideline for the estimation of fetomaternal haemorrhage · 26 min · Odcinek 87During this podcast, Matthew Hazell and Lynne Porter discuss the guideline for the estimation of fetomaternal haemorrhage, published in 2026.
- Investigation and management of thrombocytosis without JAK2, CALR or MPL mutations Guideline · 21 min · Odcinek 86During this podcast, Anna Godfrey discusses the Investigation and management of thrombocytosis without JAK2, CALR or MPL mutations Guideline, published in 2025.
- Guideline for the treatment of chronic lymphocytic leukaemia 2025 · 32 min · Odcinek 85During this podcast, Piers Patten and Renata Walewska discuss the Guideline for the treatment of chronic lymphocytic leukaemia, published in 2025.
- Guidelines for the diagnosis and management of adult aplastic anaemia · 34 min · Odcinek 84During this podcast, Dr Austin Kulasekararaj and Dr Lugain Abdalla discuss the Guidelines for the diagnosis and management of adult aplastic anaemia, published in 2024.
- Guideline on investigating and managing acquired coagulation factor inhibitors: Joint BSH–UKHCDO guidance · 24 min · Odcinek 83In this episode, Dr Charles Percy discusses the joint British Society for Haematology and United Kingdom Haemophilia Centre Doctors' Organisation Guideline on 'Laboratory…
- Updated guidelines for the diagnosis and management of tumour lysis syndrome in adults and children · 20 min · Odcinek 82Dr Tracey Chan and Dr Dima El-Sharkawi discuss the Updated guidelines for the diagnosis and management of tumour lysis syndrome in adults and children, published in 2025.
- Clinical management of bispecific antibody therapy for lymphoma Guideline podcast · 36 min · Odcinek 81Dr Matthew Wilson, Dr Sridhar Chaganti and Dr Wendy Osborne discuss the Clinical management of bispecific antibody therapy for lymphoma Good Practice Paper, published in 2025.
- Lymphoma SIG Podcast Episode 16 Choosing the optimal therapy in CLL – by Dr Toby Eyre · 30 min · Odcinek 80Dr Eyre is a consultant haematologist specialising in lymphoid malignancies in Oxford. He has completed an MD Doctorate Thesis in 2017. He is an investigator on several national…
- James Griffin Podcast - Apheresis Guideline · 32 min · Odcinek 79Podcast recording by James Griffin on the Guideline: Apheresis procedures for the treatment of patients and for the collection of cellular therapy products.
- Podcast - Guidelines on the investigation and management of antiphospholipid syndrome · 45 min · Odcinek 78Dr Deepa J. Arachchillage and Dr Jenny Tam present a review of the Guidelines on the investigation and management of antiphospholipid syndrome. Published: 04 August 2025
- Central nervous system prophylaxis in large B-cell lymphoma · 35 min · Odcinek 77Dr Matthew Wilson and Dr Kate Cwynarski discuss the Central nervous system prophylaxis in large B-cell lymphoma Good Practice Paper, published in 2024.
- Management of relapsed or refractory large B-cell lymphoma · 33 min · Odcinek 76Professor Christopher Fox, Dr Sridhar Chaganti and Dr Bernard Maybury discuss the Management of relapsed or refractory large B-cell lymphoma Guideline, published in 2025.
- Lymphoma SIG Podcast Episode 15 · 23 min · Odcinek 75
- Lymphoma Sig Podcast Episode 14 Mantle cell lymphoma – first-line treatment in 2025 – by Dr David Lewis · 42 min · Odcinek 74This podcast is the first of a series of three recordings of the Lymphoma Special Interest Group (SIG) Education Session at the 2025 BSH Annual Scientific Meeting. The Lymphoma…
- Lymphoma SIG Podcast 13 – BSH 2025 Highlights – Top Abstracts in Lymphoma with Dr Cathy Burton · 14 min · Odcinek 73Dr Cathy Burton chaired the “Top Abstracts in Lymphoma” session at BSH 2025. In this episode, she shares with us the highlights from this session. Dr Burton is a Consultant…
- Lymphoma SIG Podcast 12 – BSH 2025 Highlights in CLL with Dr Dima El-Sharkawi · 18 min · Odcinek 72Dr Dima El-Sharkawi is a Consultant Haematologist at the Royal Marsden Hospital in Sutton. Her special interests are in CLL, rare leukaemias and lymphomas as well as early phase…
- Diagnosis and management of monoclonal gammopathy of renal significance · 23 min · Odcinek 71Dr Tracey Chan and Dr Jennifer Pinney discuss the Diagnosis and management of monoclonal gammopathy of renal significance Good Practice Paper, published in January 2025.
- Lymphoma SIG Podcast 11 - BSH 2025 Highlights - Dr Sridhar Chaganti updates regarding large B cell lymphoma · 18 min · Odcinek 70In this episode, Dr Sridhar Chaganti shares with us the highlights in large B-cell lymphoma from BSH 2025, including real-world experience in the use of bispecific antibodies and…







